[SCHEDULE 13G/A] BioSig Technologies, Inc. SEC Filing
Streamex Corp. (STEX) Schedule 13G/A: Avanico Limited and Frank Giustra report collective beneficial ownership of 17,371,845 shares, representing 12.02% of the class as of the close of business on September 15, 2025. The reporting persons received 17,193,640 Exchangeable Shares in connection with a May 23, 2025 share purchase agreement; currently 5.01% of those Exchangeable Shares are exchangeable into Streamex common shares and the remainder require stockholder approval expected within 60 days. The filing explains that 178,205 Shares held by Sestini & Co., an entity controlled by Mr. Giustra, are included in the aggregate and notes that certain Shares attributed to Mr. Giustra are held in trust. This Amendment corrects an earlier reporting error in the number of Exchangeable Shares and clarifies the trust holding and event date.
- Material ownership disclosure: Reporting persons identify a substantial 12.02% beneficial ownership, improving transparency.
- Correction and clarification filed: The Amendment corrects a prior error in Exchangeable Shares and clarifies trust and entity-held shares.
- Detail on exchangeable shares: Filing explains that 17,193,640 Exchangeable Shares were issued and quantifies the portion currently exchangeable (5.01%).
- Majority of Exchangeable Shares not currently exchangeable: The remainder require stockholder approval expected within 60 days, creating uncertainty about future dilution and voting power.
- Concentrated shared voting power: Shared voting/dispositive power over 17,371,845 shares could influence corporate decisions, which may concern some investors.
Insights
TL;DR: A substantial 12.02% stake from Avanico and Frank Giustra is now publicly reported, with most exchange rights pending shareholder approval.
The disclosed 12.02% ownership is material for investors because it reflects concentrated ownership following the May 23, 2025 Share Exchange. Although 17,193,640 Exchangeable Shares were issued, only 5.01% are currently exchangeable into common stock; the balance requires stockholder approval expected within 60 days, creating short-term uncertainty about the immediate dilutive and voting effects. Inclusion of 178,205 shares held by an entity controlled by Mr. Giustra and the note that some Shares are held in trust clarify beneficial ownership and voting alignment. The amendment corrects a prior numerical error, improving filing accuracy.
TL;DR: The filing discloses concentrated, shared voting power and a pending corporate approval that will change share convertibility and potential control dynamics.
This Schedule 13G/A highlights shared voting and dispositive power over 17,371,845 shares, a meaningful minority stake at 12.02%. The large portion of Exchangeable Shares subject to stockholder approval means governance and voting outcomes could shift if conversion is approved. Clarification that certain shares are held in trust and the correction of prior reporting errors improves transparency but also signals the need for shareholders to monitor the upcoming approval vote and any related proxy communications.